Vascular risk factors and erectile dysfunction

BJU International

Volumn 87, Issue 9, 2001, Pages 838-845

  Sullivan, M E ^a   Keoghane, S R ^a   Miller, M A W ^a  

^a NORTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR; BLOOD CLOTTING FACTOR 7; CHOLESTEROL; CYCLIC GMP; DIMER; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN A; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROSTACYCLIN; PROSTAGLANDIN E RECEPTOR; RECEPTOR SUBTYPE; TISSUE PLASMINOGEN ACTIVATOR;

AGING; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DISEASE COURSE; DISEASE DURATION; ENZYME ACTIVITY; ERECTILE DYSFUNCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMPOTENCE; INCIDENCE; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING;

ARTERIOSCLEROSIS; DIABETES COMPLICATIONS; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; IMPOTENCE, VASCULOGENIC; MALE; RISK FACTORS; SMOKING;

EID: 0035723771     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2001.02211.x     Document Type: Review

References (92)

1. Age and sexual outlet
2. The prevalence of diabetic impotence
3. Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men
4. Cigarette smoking and other vascular risk factors in vasculogenic impotence
5. Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction
6. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging study
7. Incidence of erectile dysfunction in men 40-69 years old: Longitudinal results from the Massachusetts Male Aging Study
8. Impotence and aging: Clinical and hormonal factors
9. Does severity of ischaemic coronary disease correlate with erectile function
10. Impotence
11. Arterial disease as a cause of impotence
12. Erectile dysfunction due to atherosclerotic vascular disease: The development of an animal model
13. Arteriographically determined occlusive disease within the hypogastric-cavernous bed in impotent patients following blunt perineal and pelvic trauma
14. Arteriogenic impotence: Findings in 195 impotent men examined with selective internal pudendal angiography
15. Study of aetiologic relationship of arterial atherosclerosis to corporal veno-occlusive dysfunction in the rabbit
16. Effect of aging on nitric oxide-mediated penile erection in the rat
17. Erectile dysfunction in aging: Upregulation of endothelial nitric oxide synthase
18. Gene transfer of endothelial nitric oxide synthase to the penis augments erectile responses in the aged rat
19. Pharmacological studies of human erectile tissue: Characteristics of spontaneous contractions and alterations in alpha-adrenoceptor responsiveness with age and disease in isolated tissues
20. Cigarette smoking: An independent risk factor for impotence?
21. Nocturnal penile tumescence in cigarette smokers with erectile dysfunction
22. Cigarette smoking and endothelial injury: A review
23. Implication of insulin-like growth factors in the pathogenesis of diabetic neuropathy
24. Effect of chronic smoking on endothelium-dependent vascular relaxation in humans
25. Importance of risk factors in the angiographic progression of coronary artery disease
26. Ultrastructural changes in impotent penile tissue: A comparison of 65 patients
27. Effect of long-term passive smoking on erectile function and penile nitric oxide synthase in the rat
28. The effect of cigarette smoke and diabetes mellitus on muscarinic stimulation of prostacyclin synthesis by the rat penis
29. Acute vasospasm of penile arteries in response to cigarette smoking
30. The effect of cigarette smoking on penile erection
31. Impotence in diabetes. The neurologic factor
32. Sexual problems of diabetic men
33. Morphologic changes in the arterial bed of the penis with aging: Relationship to the pathogenesis of impotence
34. Diagnostic value of the penile pulse and blood pressure: A doppler study of impotence in diabetics
35. Impotence and diabetes: Histological studies of the autonomic nervous fibres of the corpora cavernosa in impotent diabetic males
36. Pathology of the penis in long-term diabetic rats
37. Decrease of vasoactive intestinal polypeptide (VIP) in the penises from impotent men
38. Changes in VIPergic, cholinergic and adrenergic innervation of human penile tissue in diabetic and non-diabetic impotent males
39. Ultrastructure of human penile erectile tissues in patients with abnormal norepinephrine content
40. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence
41. Diabetes mellitus impairs neurogenic and endothelium-mediated relaxation of rabbit corpus cavernosum smooth muscle
42. Nitric oxide and cyclic GMP formation following relaxant nerve stimulation in isolated human corpus cavernosum
43. Autoradiographic localisation of nitric oxide synthase binding sites in normal and diabetic rat corpus cavernosum
44. The effects of endothelin-1 and N-nitro-L-arginine methyl ester on regional haemodynamics in conscious rats with streptozotocin induced diabetes mellitus
45. Differential alterations of prostacyclin, cyclic AMP and cyclic GMP formation in the corpus cavernosum of the diabetic rabbit
46. Plasma and vascular tissue arginine are decreased in diabetes: Acute arginine supplementation restores endothelium-dependent relaxation by augmenting cGMP production
47. Effect of large doses of the nitric oxide precursor, L-arginine, on erectile dysfunction
48. Effect of long-term oral administration of L-arginine on the rat erectile response
49. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes
50. Advanced glycation end-products quench cavernosal nitric oxide
51. Characterisation of the fibroelastic properties of human corpus cavernosum
52. Advanced glycation end products in human penis: Elevation in diabetic tissue, site of deposition, and possible effects through iNOS or eNOS
53. Cloning of rat and human inducible penile nitric oxide synthase: Application for gene therapy for erectile dysfunction
54. Content and distribution of vasoactive intestinal polypeptide (VIP) in cavernous tissue of human penis
55. Vasoactive intestinal polypeptide-like immunoreactive nerves in diabetic penis. A comparison between streptozotocin-treated rats and man
56. Vasoactive intestinal polypeptide and impotence in experimental diabetes mellitus
57. Dysfunctional penile cholinergic nerves in diabetic impotent men
58. A comparison of the relaxation responses of isolated cavernosal smooth muscles by endothelium-independent and endothelium-dependent vasodilators in diabetic men with impotence
59. Alpha-adrenoceptor function in isolated penile circumflex veins from potent and impotent men
60. Elevated plasma endothelin in patients with diabetes mellitus
61. Endothelin-1 in diabetic and non-diabetic men with erectile dysfunction
62. The density and distribution of endothelin 1 and endothelin receptor subtypes in normal and diabetic rat corpus cavernosum
63. Alterations in endothelin B receptor sites in cavernosal tissue of diabetic rabbits: Potential relevance to the pathogenesis of diabetic erectile dysfunction
64. Endothelin-1 as a putative modulator of erectile dysfunction. II. Calcium mobilisation in cultured human corporal smooth muscle cells
65. Endothelin-1 as a putative modulator of erectile dysfunction: I. Characteristics of contraction of isolated corporal tissue strips
66. Endothelin receptor antagonists inhibit diabetic rabbit cavernosal smooth muscle cell proliferation
67. Endothelin-1 as a putative modulator of gene expression and cellular physiology in cultured human corporal smooth muscle cells
68. 1 receptors in cavernous tissue of men, monkeys and dogs
69. Adenylate and guanylate cyclase activity in the penis and aorta of the diabetic rat: An in vitro study
70. Hydrolysis of cyclic guanosine monophosphate and cyclic adenosine monophosphate in the penis and aorta of diabetic rats
71. 5′nucleotidase activity in the aorta and penis of the diabetic rat
72. Experimental diabetes mellitus inhibits prostacyclin synthesis by the rat penis; pathological implications
73. Hypertension is associated with severe erectile dysfunction
74. Sex and hypertension
75. Erectile dysfunction in hypertensive subjects. Assessment of potential deteminants
76. Effects of castration and exogenous testosterone supplementation in an animal model of penile erection
77. Morphological changes in cavernous tissue in spontaneously hypertensive rats
78. Oxidised low density lipoproteins inhibit relaxations of porcine coronary arteries
79. Oxidised LDL affects multiple atherogenic cellular responses
80. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins
81. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients
82. Hypercholesterolaemia impairs endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle
83. Experimental hypercholesterolaemia in rabbits induces cavernosal atherosclerosis with endothelial and smooth muscle cell dysfunction
84. Increased plasma endothelin in patients with hyperlipoproteinaemia and stable or unstable angina
85. Decreased endothelin B receptor binding sites on corpus cavernosa of hypercholesterolaemic rabbits
86. International Union of Pharmacology Nomenclature of endothelin receptors
87. Effect of simvastatin on coronary atheroma: The Multicentre Anti-Atheroma Study (MAAS)
88. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian simvastatin survival study
89. Fibrinogen as a cardiovascular risk factor: A meta-analysis and review of the literature
90. The possible role of blood haemorheology in atherothrombogenesis
91. Fibrinogen and hyperlipidaemia: Risk factors for impotence?
92. The effects of cigarette smoking on vascular risk factors in patients with erectile dysfunction